Is breast cancer prognosis inherited?

被引:47
作者
Hartman, Mikael
Lindstom, Linda
Dickman, Paul W.
Adami, Hans-Olov
Hall, Per
Czene, Kamila
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden
[2] Stockholm Soder Hosp, Karolinska Inst, S-11883 Stockholm, Sweden
[3] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA
关键词
D O I
10.1186/bcr1737
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction A genetic component is well established in the etiology of breast cancer. It is not well known, however, whether genetic traits also influence prognostic features of the malignant phenotype. Methods We carried out a population-based cohort study in Sweden based on the nationwide Multi-Generation Register. Among all women with breast cancer diagnosed from 1961 to 2001, 2,787 mother-daughter pairs and 831 sister pairs with breast cancer were identified; we achieved complete follow-up and classified 5-year breast cancer-specific prognosis among proband ( mother or oldest sister) into tertiles as poor, intermediary, or good. We used Kaplan-Meier estimates of survival proportions and Cox models to calculate relative risks of dying from breast cancer within 5 years depending on the proband's outcome. Results The 5-year survival proportion among daughters whose mothers died within 5 years was 87% compared to 91% if the mother was alive ( p = 0.03). Among sisters, the corresponding proportions were 70% and 88%, respectively ( p = 0.001). After adjustment for potential confounders, daughters and sisters of a proband with poor prognosis had a 60% higher 5-year breast cancer mortality compared to those of a proband with good prognosis ( hazard ratio [ HR], 1.6; 95% confidence interval [ CI], 1.2 to 2.2; p for trend 0.002). This association was slightly stronger among sisters ( HR, 1.8; 95% CI, 1.0 to 3.4) than among daughters ( HR, 1.6; 95% CI, 1.1 to 2.3). Conclusion Breast cancer prognosis of a woman predicts the survival in her first-degree relatives with breast cancer. Our novel findings suggest that breast cancer prognosis might be inherited.
引用
收藏
页数:8
相关论文
共 38 条
  • [1] Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
  • [2] Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation
    Anderson, K
    Jacobson, JS
    Heitjan, DF
    Zivin, JG
    Hershman, D
    Neugut, AI
    Grann, VR
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (06) : 397 - 406
  • [3] THE RISK OF BREAST-CANCER AFTER ESTROGEN AND ESTROGEN PROGESTIN REPLACEMENT
    BERGKVIST, L
    ADAMI, HO
    PERSSON, I
    HOOVER, R
    SCHAIRER, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) : 293 - 297
  • [4] Survival and prognostic factors in BRCA1-associated breast cancer
    Brekelmans, CTM
    Seynaeve, C
    Menke-Pluymers, M
    Brüggenwirth, HT
    Tilanus-Linthorst, MMA
    Bartels, CCM
    Kriege, M
    van Geel, AN
    Crepin, CMG
    Blom, JC
    Meijers-Heijboer, H
    Klijn, JGM
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (03) : 391 - 400
  • [5] Socioeconomic status and mortality in Swedish women:: Opposing trends for cardiovascular disease and cancer
    Cabrera, C
    Helgesson, Ö
    Wedel, H
    Björkelund, C
    Bengtsson, C
    Lissner, L
    [J]. EPIDEMIOLOGY, 2001, 12 (05) : 532 - 536
  • [6] The influence of familial and hereditary factors on the prognosis of breast cancer
    Chappuis, PO
    Rosenblatt, J
    Foulkes, WD
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (10) : 1163 - 1170
  • [7] Weight loss in breast cancer patient management
    Chlebowski, RT
    Aiello, E
    McTiernan, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 1128 - 1143
  • [8] The role of genetic variability in drug metabolism pathways in breast cancer prognosis
    Choi, Ji-Yeob
    Nowell, Susan A.
    Blanco, Javier G.
    Ambrosone, Christine B.
    [J]. PHARMACOGENOMICS, 2006, 7 (04) : 613 - 624
  • [9] A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors
    Collett, K
    Stefansson, IM
    Eide, J
    Braaten, A
    Wang, H
    Eide, GE
    Thoresen, SO
    Foulkes, WD
    Akslen, LA
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) : 1108 - 1112
  • [10] A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers
    Cozma, D
    Lukes, L
    Rouse, J
    Qiu, TH
    Liu, ET
    Hunter, KW
    [J]. GENOME RESEARCH, 2002, 12 (06) : 969 - 975